Европейски съюз - естонски - EMA (European Medicines Agency)

shire pharmaceutical contracts limited - epoetiin delta - kidney failure, chronic; anemia - antianemilised preparaadid - dynepo on näidustatud täiskasvanud patsientidel kroonilise neerupuudulikkusega (crf) seotud sümptomaatilise aneemia raviks. seda võib kasutada dialüüsi ja dialüüsi mitte saavatel patsientidel.

Европейски съюз - естонски - EMA (European Medicines Agency)

dechra regulatory b.v. - betamethasone acetate, terbinafine, florfenicol - kortikosteroidid ja antiinfectives koos - koerad - Ägeda keskkõrvapõletiku ravi.

Естония - естонски - Ravimiamet

deltamedica gmbh - ropivakaiin - infusioonilahus - 2mg 1ml 100ml 10tk

Европейски съюз - естонски - EMA (European Medicines Agency)

roche registration gmbh - metoksü polüetüleenglükool-epoetin beta - anemia; kidney failure, chronic - antianemilised preparaadid - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.

Европейски съюз - естонски - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - follitropiin delta - anovulatsioon - suguhormoonid ja genitaalsüsteemi, - mitme folliikulite toimuvad kunstliku viljastamise (art) nagu in vitro viljastamise (ivf) või spermatosoidi intratsütoplasmaatiline injektsioon (icsi) tsükli naistel munasarjade kontrollitud.

Естония - естонски - Ravimiamet

ceva-phylaxia zrt. - lindude rinotrahheiidi viirusvaktsiin - okulonasaalsuspensiooni lüofilisaat - 1annus 500annus 20tk; 1annus 5000annus 1tk; 1annus 2500annus 1tk; 1annus 500annus 10tk; 1annus 4000annus 20tk; 1annus 2000annus 1tk; 1annus 3000annus 10tk; 1annus 5000annus 10tk; 1annus 1000annus 10tk; 1annus 2000annus 10tk; 1annus 3000annus 20tk; 1annus 2500annus 10tk; 1annus 3000annus 1tk; 1annus 500annus 1tk; 1annus 1000annus 20tk; 1annus 2000annus 20tk; 1annus 2500annus 20tk

Естония - естонски - Ravimiamet

ceva sante animale - progesteroon - vaginaalravivahend - 1,55g 10tk; 1,55g 25tk; 1,55g 100tk; 1,55g 50tk

Европейски съюз - естонски - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - muud antianemic preparaadid - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

Европейски съюз - естонски - EMA (European Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorraagilised ained - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Естония - естонски - Ravimiamet

glenwood gmbh pharmazeutische erzeugnisse - betanekool - tablett - 25mg 50tk